Senisca raised £3.7m with Emerging Longevity Ventures, QantX, R42 Group, Trend Investment Group, Apex Ventures and Lifespan Vision Ventures. Biotech Health services Manufacturing Pharma Investments 08 March 2024 Share: Original story Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!
Round value (USD): 4.66M Round investors: Trend Investment GroupQantXEmerging Longevity VenturesLifespan Vision VenturesApex VenturesR42 Group Company: Senisca Industry: BiotechHealth servicesManufacturingPharma
Combat Medical secured £2.6 million series A led by the T&J Meyer Family Foundation, with participation from Varia Ventures, NW Angel Fund Health services Manufacturing Investments 02 March 2026
Sequential in a $3.5 million seed round co-led by Sparkfood and Corundum Systems Biology, joined by Dermazone Holdings, SOSV, Scrum Ventures Biotech Ecommerce Health services Pharma Investments 02 March 2026
Biocaptiva raised £1.58m in funding led by Archangels, joined by Old College Capital, BBI, Scottish Enterprise, and new investor EverQuest Capital Partners. Biotech Health services Manufacturing Investments 01 March 2026
Spotlight Pathology raised £1.4 million in seed investment with the UK Innovation and Science Seed Fund, managed by Future Planet Capital AI (big data) Competitive Intelligence Health services Pharma Software Services Investments 01 March 2026
Ternary Therapeutics raised €4.1M seed round led by daphni, joined by Pace Ventures, i&i Biotech Fund, and Future Planet Capital. AI (big data) Biotech Health services Software Services Investments 01 March 2026